[Clinical and laboratory evaluation of prolonged administration of microdoses of d-Norgestrel].
D002463:Cell Membrane Permeability / Q000187:drug effects; D002582:Cervix Mucus / Q000187:drug effects; D003267:Contraception; D004717:Endometrium / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects*; D008099:Liver / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000097:blood; D009644:Norgestrel / Q000008:administration & dosage / Q000494:pharmacology*; D010053:Ovary / Q000187:drug effects*; D010902:Pituitary Gland / Q000187:drug effects; D011247:Pregnancy; D013997:Time Factors
D009644:Norgestrel; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Surveillance clinique et biologique durant l'administration prolongeé d'une faible dose de d-norgestrel